Angiotech - Redefining Success™
Search
  • About Us
    • Corporate Profile
    • Company History
    • Management Team
    • Intellectual Property
  • Products
    • Product Overview
    • Quill™ SRS
    • 5FU - CVC
    • Interventional
    • Biopsy
    • Ophthalmic
    • Surgical
    • Angiotech Partner Solutions
    • Private Label
  • Healthcare Professionals
    • About...
  • Investors
    • Investor Overview
    • Corporate Governance
    • Events & Webcasts
    • Quarterly Results
    • Proxy Materials
    • SEC Filings
    • Request Information
  • News
    • Press Releases
    • Email Alerts
  • Careers
  • Contact Us

 Surgical Hemostats

Print

Home › technology/medical-devices › Surgical Hemostats

Hemostatic devices are used to control bleeding during surgeries to ensure effective closure of surgical wounds and to avoid serious or life-threatening complications which include; blood loss, tissue damage, infection and excessive scarring.

Vitagel™ Surgical Hemostat, is designed for use in cardiovascular, orthopedic, urologic and general surgery indications to control bleeding. Vitagel differs from other competitors in that it uses autologous (a patient's own) blood as opposed to products from pooled donor blood, thus reducing the risk of transmission of diseases associated with donor blood. In June 2000, Vitagel received approval from the United States Food and Drug Administration, or FDA, for marketing in the U.S.

Angiotech has entered into a license agreement with Orthovita, Inc. with a focus on spinal indications. Angiotech has retained all development and commercial rights for a drug-loaded version of this product.

Quick Links

  • Product Overview
  • Events & Webcasts
  • Latest Quarterly Results
  • Press Releases

Home

  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Careers

About Us

  • Corporate Profile
  • Company History
  • Management Team
  • Intellectual Property

Products

  • Product Overview
  • Quill™ SRS
  • 5FU - CVC
  • Interventional
  • Biopsy
  • Ophthalmic
  • Surgical
  • Angiotech Partner Solutions
  • Private Label

Investors

  • Investor Overview
  • Corporate Governance
  • Events & Webcasts
  • Quarterly Results
  • Proxy Materials
  • SEC Filings
  • Request Information

News

  • Press Releases
  • Email Alerts

© Copyright 2010 Angiotech. All Rights Reserved.